Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1973 May;27(5):370–389. doi: 10.1038/bjc.1973.45

Similarities of the Anti-tumour Actions of Endotoxin, Lipid A and Double-stranded RNA

I Parr, E Wheeler, P Alexander
PMCID: PMC2008799  PMID: 4713170

Abstract

Double stranded RNA (dsRNA) whether isolated from a fungal virus or prepared synthetically (i.e., Poly I Poly C) and endotoxin were found to exert very similar effects on syngeneic murine lymphomata and fibrosarcomata. They cause complete regressions of some established subcutaneous (s.c.) or intradermal (i.d.) tumours but not of intraperitoneal (i.p.) tumours when administered either systemically or directly into the tumour. To achieve this effect the tumours must be fully established and the best results were obtained when treatment was started 7 days after transplant. If treatment is started within the first 3 days following the transplantation of the tumour then only a slight inhibition of growth rate was observed. These agents can also act prophylactically and protect mice against a subsequent challenge but only if this is given i.p. and not if given s.c. or i.d. The prophylactic action is explained by the action of dsRNA and endotoxin on peritoneal macrophages which cause them to become cytotoxic to tumour cells (i.e., to become activated).

The therapeutic effect of systemically administered endotoxin and dsRNA on established tumours is not the result of a direct action on the tumour cells themselves but is a complex process requiring the co-operation of several host factors. Haemorrhagic necrosis involving coagulation is essential (i.e., heparinization reduces the regression of tumours) but is not itself sufficient. Immunosuppression by whole body irradiation or by antilymphocyte serum also interferes with the antitumour action of dsRNA and endotoxin in spite of the fact that haemorrhagic necrosis still occurs. Also, the magnitude of the antitumour action correlated in a series of different tumours with their antigenicity. The observed tumour regressions are probably brought about by (1) vascular damage in the tumour which permits immune defence mechanisms of the host to gain access to the tumour and (2) activation of macrophages present within the tumour. The relative contribution of these two mechanisms may depend on the nature of the tumour and the route of administration of the active agents.

Dibenyline, which protects against the lethal action of endotoxin by preventing the action of the catecholamines on the α-adrenergic receptors, makes it possible to increase the effectiveness of endotoxin in tumours by allowing a large dose to be given. Lipid A, a derivative of endotoxin which does not contain polysaccharide, has similar antitumour action to dsRNA and endotoxin. Some common features of the chemical structure of lipid A and dsRNA are discussed.

Full text

PDF
380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P., Evans R. Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol. 1971 Jul 21;232(29):76–78. doi: 10.1038/newbio232076a0. [DOI] [PubMed] [Google Scholar]
  2. Dröge W., Lehmann V., Lüderitz O., Westphal O. Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem. 1970 May 1;14(1):175–184. doi: 10.1111/j.1432-1033.1970.tb00276.x. [DOI] [PubMed] [Google Scholar]
  3. ECKENHOFF J. E., COOPERMAN L. H. THE CLINICAL APPLICATION OF PHENOXYBENZAMINE IN SHOCK AND VASOCONSTRICTIVE STATES. Surg Gynecol Obstet. 1965 Sep;121:483–490. [PubMed] [Google Scholar]
  4. Evans R. Macrophages in syngeneic animal tumours. Transplantation. 1972 Oct;14(4):468–473. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  5. Fisher J. C., Cooperband S. R., Mannick J. A. The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors. Cancer Res. 1972 May;32(5):889–892. [PubMed] [Google Scholar]
  6. GOOD R. A., THOMAS L. Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reactions with heparin. J Exp Med. 1953 Jun;97(6):871–888. doi: 10.1084/jem.97.6.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Galanos C., Rietschel E. T., Lüderitz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem. 1971 Mar 1;19(1):143–152. doi: 10.1111/j.1432-1033.1971.tb01298.x. [DOI] [PubMed] [Google Scholar]
  8. Gmeiner J., Lüderitz O., Westphal O. Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. Eur J Biochem. 1969 Jan;7(3):370–379. doi: 10.1111/j.1432-1033.1969.tb19618.x. [DOI] [PubMed] [Google Scholar]
  9. Halpern B. N., Biozzi G., Stiffel C., Mouton D. Inhibition of tumour growth by administration of killed corynebacterium parvum. Nature. 1966 Nov 19;212(5064):853–854. doi: 10.1038/212853a0. [DOI] [PubMed] [Google Scholar]
  10. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol. 1972 Jan 12;235(54):48–50. doi: 10.1038/newbio235048a0. [DOI] [PubMed] [Google Scholar]
  11. Hilleman M. R. Double-stranded RNAs (poly I:C) in the prevention of viral infections. Arch Intern Med. 1970 Jul;126(1):109–124. [PubMed] [Google Scholar]
  12. LEVY E. Z., NORTH W. C., WELLS J. A. Modification of traumatic shock by adrenergic blocking agents. J Pharmacol Exp Ther. 1954 Oct;112(2):151–157. [PubMed] [Google Scholar]
  13. Levy H. B. Interferon and interferon inducers in the treatment of malignancies. Arch Intern Med. 1970 Jul;126(1):78–83. [PubMed] [Google Scholar]
  14. Levy H. B., Law L. W., Rabson A. S. Inhibition of tumor growth by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Feb;62(2):357–361. doi: 10.1073/pnas.62.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lüderitz O. Recent results on the biochemistry of the cell wall lipopolysaccharides of Salmonella bacteria. Angew Chem Int Ed Engl. 1970 Sep;9(9):649–663. doi: 10.1002/anie.197006491. [DOI] [PubMed] [Google Scholar]
  16. Mathé G., Pouillart P., Lapeyraque F. Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells. Br J Cancer. 1969 Dec;23(4):814–824. doi: 10.1038/bjc.1969.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. OLD L. J., BENACERRAF B., CLARKE D. A., CARSWELL E. A., STOCKERT E. The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 1961 Oct;21:1281–1300. [PubMed] [Google Scholar]
  18. Parr I. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972 Jun;26(3):174–182. doi: 10.1038/bjc.1972.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pilch D. J., Planterose D. N. Effects of Friend disease of double-stranded RNA of fungal origin. J Gen Virol. 1971 Feb;10(2):155–162. doi: 10.1099/0022-1317-10-2-155. [DOI] [PubMed] [Google Scholar]
  20. Planterose D. N., Birch P. J., Pilch D. J., Sharpe T. J. Antiviral activity of double stranded RNA and virus-like particles from Penicillium stoloniferum. Nature. 1970 Aug 1;227(5257):504–505. doi: 10.1038/227504a0. [DOI] [PubMed] [Google Scholar]
  21. Sutthiwan P., Shorter R. G., Hallenbeck G. A., Elveback L. R. Comparison of rabbit antimouse thymus sera produced after different numbers of injections of lymphoid cells. Transplantation. 1969 Sep;8(3):249–257. doi: 10.1097/00007890-196909000-00006. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES